IL6 and ovarian carcinoma: IL-6 upregulates the expression of multidrug resistance gene 1 (MDR-1) and glutathione transferase (GST-π), thus facilitating drug efflux which is regarded as an important cause of multidrug resistance (MDR) development in ovarian cancer.